← Back to all trials
Not Yet Recruiting
NCT07665827
Efficacy and Safety of Antihypertensive Treatment With Mobile Stroke Units in Ultra-Early Intracerebral Hemorrhage
Conditions: Nervous System Diseases, Cerebrovascular Disorders, Cardiovascular Diseases, Vascular Diseases, Hemorrhage, Intracranial Hemorrhages, Cerebral Hemorrhage, Cerebral Hemorrhage, Hypertensive, Stroke, Hemorrhagic Stroke, Intracerebral
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 706
Sponsor: Xuanwu Hospital, Beijing
Location: Xuanwu Hospital Beijing Beijing Municipality
Summary
MSU-ICH is a prospective, multicenter, Week-wise-randomized, open-label, blinded-endpoint (PROBE) clinical trial comparing ultra-early prehospital blood pressure lowering delivered by a Mobile Stroke Unit (MSU) with standard Emergency Medical Services (EMS) in patients with spontaneous intracerebral hemorrhage.
Eligibility Criteria
Inclusion Criteria:
1. History and physical/neurological examination consistent with acute stroke.
2. Age ≥18 years;
3. Time from symptom onset to enrollment \
Source: ClinicalTrials.gov (NCT07665827). StuddyBuddy aggregates publicly available trial information.
